Invesco Dynamic Biotechnology & Genome ETF (PBE) Price & Chart
PBE ETF Chart & Stats
- Day’s Range
- $102.29 - $104.24
- 52-Week Range
- $73.16 - $104.24
- Previous Close
- $103.46
- Volume
- 13.14K
- Average Volume (3M)
- 30.35K
- AUM
- 445.63M
- NAV
- 102.50
- Expense Ratio
- 0.59%
- Holdings Count
- 32
- Beta
- 0.66
- Inception Date
- Jun 23, 2005
- Last Dividend Ex-Date
- Sep 21, 2026
- Dividend Yield
- (1.30%)
- Shares Outstanding
- 4,310,000
- Standard Deviation
- N/A
ETF Overview
Invesco Dynamic Biotechnology & Genome ETF
The Invesco Dynamic Biotechnology & Genome ETF (PBE) is a specialized exchange-traded fund that offers investors a targeted opportunity to engage with the cutting-edge biotechnology sector within the broader health care industry. This ETF is meticulously designed to capture the growth potential of companies at the forefront of biotechnological innovation and genomic research, an area that is transforming the future of medicine and therapeutics. By investing in PBE, stakeholders gain exposure to a dynamic portfolio of firms that are pioneering advancements in genetic engineering, molecular biology, and biopharmaceutical development. With a focus on both established leaders and emerging innovators in the biotechnology niche, PBE provides a balanced approach to tapping into the sector's rapid growth and scientific breakthroughs. Ideal for those looking to leverage sector-specific growth trends, this ETF stands out for its strategic emphasis on companies that are shaping the future of healthcare solutions, making it a compelling choice for forward-thinking investors.